W
2.99
-0.18 (-5.68%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Whitehawk Therapeutics, Inc. | 混合的 | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.2 |
| 技术平均移动指标 | -1.5 |
| 技术振荡指标 | -2.5 |
| 相对估值 | NA |
| 财务健康 | -5.0 |
| 宏观环境 | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -1.45 |
|
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 12.44% |
| 机构持股比例 | 67.64% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Yu Fan | 30 Jun 2026 | 4,861,314 |
| Acuta Capital Partners, Llc | 30 Jun 2026 | 4,685,912 |
| Qvt Financial Lp | 30 Jun 2026 | 4,615,709 |
| Montanova Capital, Llc | 30 Jun 2026 | 4,300,000 |
| Orbimed Advisors Llc | 30 Jun 2026 | 3,934,296 |
| Avoro Capital Advisors Llc | 30 Jun 2026 | 2,849,402 |
| Siren, L.L.C. | 30 Jun 2026 | 2,337,102 |
| Kvp Capital Advisors, Lp | 30 Jun 2026 | 2,165,997 |
| Acorn Capital Advisors, Llc | 30 Jun 2026 | 1,139,363 |
该时间范围内无数据。
该时间范围内无数据。
投资组合